Arkansas Legal Resource Navigator

10 U.S.C. § 177 — American Registry of Pathology

Federal law — U.S. Code and appendices · legal_authorities

10 U.S.C. § 177 — American Registry of Pathology

**(a)** (1) There is authorized to be established a nonprofit corporation to be known as the American Registry of Pathology which shall not for any purpose be an agency or establishment of the United States Government. The American Registry of Pathology shall be subject to the provisions of this section and, to the extent not inconsistent with this section, to the District of Columbia Nonprofit Corporation Act (D.C. Code, sec. 29–501 et seq.). (2) The American Registry of Pathology shall have a Board of Members (hereinafter in this section referred to as the “Board”) consisting of not less than eleven individuals who are representatives of the professional societies and organizations that support the activities of the American Registry of Pathology, of whom one shall be elected annually by the Board to serve as chairman. (3) The American Registry of Pathology shall have a Director, who shall be appointed by the Board, and such other officers as may be named and appointed by the Board. Such officers shall be compensated at rates fixed by the Board and shall serve at the pleasure of the Board. (4) The members of the initial Board shall serve as incorporators and shall take whatever actions are necessary to establish under the District of Columbia Nonprofit Corporation Act the corporation authorized by paragraph (1). (5) The term of office of each member of the Board shall be four years, except that (A) any member appointed to fill a vacancy occurring prior to the expiration of the term for which his predecessor was appointed shall be appointed for the remainder of such term, (B) the terms of office of members first taking office shall begin on the date of incorporation and shall expire, as designated at the time of their appointment and to the maximum extent practica

Source: Supplied U.S. Code snapshot — release unconfirmed · 10 U.S.C. § 177

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 84ce9e40a043a7bc969272a58b861b5dd5cadbf895c87a58aa154c343c664e68. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_6bc8fb60a51bff7c371e3bd8
Source file: Laws/federal/codes/united-states-code/title-10/section-177-american-registry-of-pathology--729bb5a79d.md
Pages: Not recorded – Not recorded
Passage SHA-256: 8ec7293ff0e20f5f2b5c2bc846137aa4e5d7b2e822e912a45441bf7c28d13f98

Source location: Title 10, Chapter 7, § 177; chapter-007-boards-councils-and-committees.md

Stored source content

**(a)** (1) There is authorized to be established a nonprofit corporation to be known as the American Registry of Pathology which shall not for any purpose be an agency or establishment of the United States Government. The American Registry of Pathology shall be subject to the provisions of this section and, to the extent not inconsistent with this section, to the District of Columbia Nonprofit Corporation Act (D.C. Code, sec. 29–501 et seq.). (2) The American Registry of Pathology shall have a Board of Members (hereinafter in this section referred to as the “Board”) consisting of not less than eleven individuals who are representatives of the professional societies and organizations that support the activities of the American Registry of Pathology, of whom one shall be elected annually by the Board to serve as chairman. (3) The American Registry of Pathology shall have a Director, who shall be appointed by the Board, and such other officers as may be named and appointed by the Board. Such officers shall be compensated at rates fixed by the Board and shall serve at the pleasure of the Board. (4) The members of the initial Board shall serve as incorporators and shall take whatever actions are necessary to establish under the District of Columbia Nonprofit Corporation Act the corporation authorized by paragraph (1). (5) The term of office of each member of the Board shall be four years, except that (A) any member appointed to fill a vacancy occurring prior to the expiration of the term for which his predecessor was appointed shall be appointed for the remainder of such term, (B) the terms of office of members first taking office shall begin on the date of incorporation and shall expire, as designated at the time of their appointment and to the maximum extent practicable, one fourth at the end of one year, one fourth at the end of two years, one fourth at the end of three years, and one fourth at the end of four years, and (C) a member whose term has expired may serve until his successor has qualified. No member shall be eligible to serve more than two consecutive terms of four years each. (6) Any vacancy in the Board shall not affect its powers, but such vacancy shall be filled in the manner in which the original appointment was made. **(b)** In order to carry out the purposes of this section, the American Registry of Pathology is authorized to— (1) enter into contracts with public and private organizations for the writing, editing, printing, and publishing of fascicles of tumor pathology, atlases, and other material; (2) accept gifts and grants from and enter into contracts with individuals, private foundations, professional societies, institutions, and governmental agencies; (3) enter into agreements with professional societies for the establishment and maintenance of Registries of Pathology; and (4) serve as a focus for the interchange between military and civilian pathology and encourage the participation of medical, dental, and veterinary sciences in pathology for the mutual benefit of military and civilian medicine. **(c)** In the performance of the functions set forth in subsection (b), the American Registry of Pathology is authorized to— (1) enter into such other contracts, leases, cooperative agreements, or other transactions as the Board deems appropriate to conduct the activities of the American Registry of Pathology; and (2) charge such fees for professional services as the Board deems reasonable and appropriate. **(d)** The American Registry of Pathology may transmit annually to its Board and supporting organizations referred to in subsection (a)(2) a comprehensive and detailed report of its operations, activities, and accomplishments.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

10 U.S.C. § 176 — Armed Forces Institute of Pathology

**(a)** (1) There is in the Department of Defense an Institute to be known as the Armed Forces Institute of Pathology (hereinafter in this section referred to as the “Institute”), which has the responsibilities, functions, authority, and relationships set forth in this section. The Institute shall be a joint entity of the three military departments, subject to the authority, direction, and control of the Secretary of Defense. (2) The Institute shall consist of a Board of Governors, a Director, two Deputy Directors, and a staff of such professional, technical, and clerical personnel as may be required. (3) The Board of Governors shall consist of the Assistant Secretary of Defense for Health Affairs, who shall serve as chairman of the Board of Governors, the Assistant Secretary of Health and Human Services for Health, the Surgeons General of the Army, Navy, and Air Force, the Under Secretary for Health of the Department of Veterans Affairs, and a former Director of the Institute, as designated by the Secretary of Defense, or the designee of any of the foregoing. (4) The Director and the Deputy Directors shall be appointed by the Secretary of Defense. **(b)** (1) In carrying out the provisions of this section, the Institute is authorized to— (A) contract with the American Registry of Pathology (established under [section 177 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title10-section177&num=0&edition=prelim)) for cooperative enterprises in medical research, consultation, and education between the Institute and the civilian medical profession under such conditions as may be agreed upon between the Board of Governors and the American Registry of Pathology; (B) make available at no cost to the American Registry of Pathology such spa

Source: Supplied U.S. Code snapshot — release unconfirmed · 10 U.S.C. § 176

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

10 U.S.C. § 177 — American Registry of Pathology

Page 264 TITLE 10—ARMED FORCES § 177 ESTABLISHMENT OF JOINT PATHOLOGY CENTER Pub. L. 110–181, div. A, title VII, § 722, Jan. 28, 2008, 122 Stat. 199, provided that: ‘‘(a) FINDINGS.—Congress makes the following find- ings: ‘‘(1) The Secretary of Defense proposed to disestab- lish all elements of the Armed Forces Institute of Pa- thology, except the National Medical Museum and the Tissue Repository, as part of the recommenda- tions of the Secretary for the closure of Walter Reed Army Medical Center in the 2005 round of defense base closure and realignment. ‘‘(2) The Defense Base Closure and Realignment Commission altered, but did not reject, the proposal of the Secretary of Defense to disestablish the Armed Forces Institute of Pathology. ‘‘(3) The Commission’s recommendation that the Armed Forces Institute of Pathology’s ‘capabilities not specified in this recommendation will be absorbed into other DOD, Federal, or civilian facilities’ pro- vides the flexibility to retain a Joint Pathology Cen- ter as a Department of Defense or Federal entity. ‘‘(b) SENSE OF CONGRESS.—It is the sense of Congress that the Armed Forces Institute of Pathology has pro- vided important medical benefits to the Armed Forces and to the United States and that the Federal Govern- ment should retain a Joint Pathology Center. ‘‘(c) ESTABLISHMENT.— ‘‘(1) ESTABLISHMENT REQUIRED.—The President shall establish and maintain a Joint Pathology Center that shall function as the reference center in pathology for the Federal Government. ‘‘(2) ESTABLISHMENT WITHIN DOD.—Except as pro- vided in paragraph (3), the Joint Pathology Center shall be established in the Department of Defense, consistent with the final recommendations of the 2005 Defense Base Closure and Realignment Commission,

Source: Supplied 2024 U.S. Code historical extraction · 10 U.S.C. § 177

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.